Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement

Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement

Introduction: Treatment of hemophilia A in Brazil is offered to all patients at no cost. However, several unmet medical needs exist. Method: In this study, we applied the Delphi method to discuss with seven hemophilia A specialists the challenges that patients and the health system face regarding he...

Full description

Bibliographic Details
Main Authors: Margareth Castro Ozelo, Sandra Vallin Antunes, Paula Ribeiro Villaca, Luciana Correa Oliveira, Ieda Solange Pinto, Claúdia Santos Lorenzato, Alessandra Nunes Loureiro Prezotti, Renato Mantelli Picoli
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Hemophilia A
Factor VIII
Hemophilia replacement treatment
Delphi method
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137922014705

Internet

http://www.sciencedirect.com/science/article/pii/S2531137922014705

Similar Items